Furthermore, the overexpression of HOXA5 has been shown to suppress the invasion capacity of pulmonary carcinoma cells.[36] Consequently, we posit that HOXA5 may serve as a potent inhibitor of NSCLC. Here, HOXA5 is linked to non-small cell lung carcinoma.